Prognostic effect of different cut-off values (20 mm, 30 mm and 40 mm) for clinical tumor size in FIGO stage IB cervical cancer

Surgical Oncology

Volumn 19, Issue 2, 2010, Pages 106-113

  Turan, Taner ^a   Yildirim, Bunyamin ^a   Tulunay, Gokhan ^a   Boran, Nurettin ^a   Kose, Mehmet Faruk ^a  

^a Department of Obstetrics and Gynecology   (Turkey)

Author keywords

Cervical cancer; Surgical pathologic risk factor; Survival; Tumor size

Indexed keywords

ADULT; AGE; AGED; CANCER CLASSIFICATION; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENERAL ANESTHESIA; GENITAL SYSTEM EXAMINATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 77952553656     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2009.04.004     Document Type: Review

References (20)

1. Creasman W.T. New gynecologic cancer staging. Gynecol Oncol 58 2 (1995) 157-158
2. Rutledge T.L., Kamelle S.A., Tillmanns T.D., Gould N.S., Wright J.D., Cohn D.E., et al. A comparison of stage IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?. Gynecol Oncol 95 (2004) 70-76
3. Horn L.C., Fischer U., Raptis G., Bilek K., and Hentschel B. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 107 (2007) 310-315
4. Finan M.A., DeCesare S., Fiorica J.V., Chambers R., Hoffman M.S., Kline R.C., et al. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?. Gynecol Oncol 62 (1996) 139-147
5. Sevin B.U., Nadji M., Lampe B., Lu Y., Hilsenbeck S., Koechli O.R., et al. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer 76 (1995) 1978-1986
6. Kristensen G.B., Abeler V.A., Risberg B., Trope C., and Bryne M. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol 74 (1999) 245-251
7. Wagenaar H.C., Trimbos J.B., Postema S., Anastasopoulou A., van der Geest R.J., Reiber J.H., et al. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer. Gynecol Oncol 82 (2001) 474-482
8. Chung C.K., Nahhas W.A., Stryker J.A., Curry S.L., Abt A.B., and Mortel R. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 138 (1980) 550-556
9. Wagenaar H.C., Trimbos J.B., Postema S., Anastasopoulou A., van der Geest R.J., Reiber J.H., et al. Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage 1B cervical cancer. Cancer 63 (1989) 2220-2223
10. Delgado G., Bundy B.N., Fowler Jr. W.C., Stehman F.B., Sevin B., Creasman W.T., et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 35 (1989) 314-320
11. Homesley H.D., Raben M., Blake D.D., Ferree C.R., Bullock M.S., Linton E.B., et al. Relationship of lesion size to survival in patients with stage IB squamous cell carcinoma of the cervix uteri treated by radiation therapy. Surg Gynecol Obstet 150 (1980) 529-531
12. Perez C.A., Grigsby P.W., Chao K.S., Mutch D.G., and Lockett M.A. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 41 (1998) 307-317
13. Sardi J., Sananes C., Giaroli A., Bayo J., Rueda N.G., Vighi S., et al. Results of a prospective trial with neoadjuvant chemotherapy in stage IB bulky, squamous carcinoma of the cervix. Gynecol Oncol 49 2 (1993) 156-165
14. Burghardt E., and Pickel H. Local spread and lymph node involvement in cervical cancer. Obstet Gynecol 52 (1978) 138-145
15. Kamelle S.A., Rutledge T.L., Tillmanns T.D., Gould N.S., Cohn D.E., Wright J., et al. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?. Gynecol Oncol 94 (2004) 249-255
16. Kovalic J.J., Perez C.A., Grigsby P.W., and Lockett M.A. The effect of volume of disease in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 21 (1991) 905-910
17. Lee J.M., Lee K.B., and Park C.Y. Prognostic factors predicting survival in patients with FIGO stage IB cervical cancer treated surgically. Int J Gynaecol Obstet 94 (2006) 143-144
18. Comerci G., Bolger B.S., Flannelly G., Maini M., de Barros Lopes A., and Monaghan J.M. Prognostic factors in surgically treated stage IB-IIB carcinoma of the cervix with negative lymph nodes. Int J Gynecol Cancer 8 (1998) 23-26
19. Trimbos J.B., Lambeek A.F., Peters A.A., Wolterbeek R., Gaarenstroom K.N., Fleuren G.J., et al. Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer. Gynecol Oncol 95 (2004) 77-81
20. Stehman F.B., Bundy B.N., DiSaia P.J., Keys H.M., Larson J.E., and Fowler W.C. Carcinoma of the cervix treated with radiation therapy. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67 (1991) 2776-2785